Efficacy of combined, sequential and crossover psychotherapy and pharmacotherapy in improving outcomes in depression
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
There is a growing recognition that relapse and recurrence after the successful treatment of major depression is a common and debilitating outcome that has massive social costs. Although many patients achieve a sustained recovery with maintenance pharmacotherapy, the long-term outcome for a significant proportion of patients is still poor. The purpose of this review is to evaluate the role of combined psychological and pharmacological therapies in minimizing relapse and recurrence in the treatment of depression. Three approaches have been investigated: concurrent treatment, sequential treatment and crossover treatment. Concurrent therapy is as effective as monotherapy for the treatment of mild-to-moderate depressive disorder and shows evidence of a potential treatment advantage in cases where depression is more severe. Consecutive sequencing of pharmacotherapy and psychotherapy has demonstrated some benefit for both the conversion of partial to full response and the prevention of relapse and recurrence, especially in more severely depressed patients. Crossover treatments during the maintenance phase (i.e., switching patients from one treatment to a second after an adequate response to the first) show evidence of being beneficial in preventing relapse and recurrence. Variants of cognitive therapy that have been modified to specifically address residual symptoms in patients who have recovered from depression appear to be the most effective. A review of the studies to date indicates that cognitive therapy may play a role in improving remission rates and decreasing relapse and recurrence rates. Although most studies are small, there is a consistent suggestion of superior prophylaxis for patients receiving some type of sequenced or crossover treatment in which the delivery of antidepressant medication and structured antidepressant psychotherapy is combined. These approaches warrant greater attention; they may present another route for enhancing long-term recovery from major depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.
Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.4.615 · Cited by 3,236 · cited 2×
“A number of variants of cognitive therapy (CT) approaches have also been described including mindfulness-based CT (MBCT), which focuses on changing the awareness of thoughts rather than their content.(12) Other variants have been designed to specifically target symptoms that remain after antidepressant therapy.”
Self-citationKeller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., Markowitz, J. C., Nemeroff, C. B., Russell, J. M., Thase, M. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422001 · Cited by 1,331 · cited 3×
“001).(11) Similarly, remission rates were significantly higher for the combination group than they were for CBASP or nefazodone alone (42% v.”
InfluentialReynolds III, C. F., Frank, E., Perel, J. M., Imber, S. D., Cornes, C., Miller, M. D., Mazumdar, S., Houck, P. R., Dew, M. A., Stack, J. A., et al. (1999) · JAMA · doi:10.1001/jama.281.1.39 · Cited by 659
Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations
Thase, M. E. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830230043006 · Cited by 515 · cited 1×
“A “mega”-analysis of pooled data of 595 patients with unipolar MDD provided evidence that combined therapy was superior to psychotherapy alone, particularly in the treatment of more severe recurrent depression.(16) Patients received 16 weeks of CT alone, IPT alone or IPT and antidepressant therapy.”
Prevention of Recurrent Depression With Cognitive Behavioral Therapy: Preliminary Findings
Fava, G. A., Rafanelli, C., Grandi, S., Conti, S., & Belluardo, P. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.9.816 · Cited by 491
Cognitive Therapy and Pharmacotherapy for Depression: Singly and in Combination
Hollon, S. D. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820100018004 · Cited by 481
BLACKBURN, I., EUNSON, K., & BISHOP, S. (1986) · Journal of Affective Disorders · doi:10.1016/0165-0327(86)90050-9 · Cited by 338 · cited 2×
“Although most patients maintained their improvement, 30% in the TCA group, 6% in the CT group and no patients in the combined treatment group had relapsed at 6 months.(14) This pattern was maintained over the 2-year follow-up period, suggesting a preventative effect with acute CT.”
Six-Year Outcome for Cognitive Behavioral Treatment of Residual Symptoms in Major Depression
Fava, G. A., Rafanelli, C., Grandi, S., Canestrari, R., & Morphy, M. A. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1443 · Cited by 299
Cognitive behavioral treatment of residual symptoms in primary major depressive disorder
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.9.1295 · Cited by 266
Treatment of Depression in General Practice
Johnson, D. A. W. (1973) · BMJ · doi:10.1136/bmj.2.5857.18 · Cited by 133
Cited by
Drossman, D. A., Toner, B. B., Whitehead, W. E., Diamant, N. E., Dalton, C. B., Duncan, S., Emmott, S., Proffitt, V., Akman, D., Frusciante, K., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00669-3 · Cited by 614
The burden of severe depression: A review of diagnostic challenges and treatment alternatives
Nemeroff, C. B. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.05.008 · Cited by 295
A systematic review of comparative efficacy of treatments and controls for depression
Khan, A., Faucett, J., Lichtenberg, P., Kirsch, I., & Brown, W. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041778 · Cited by 288
Chaves, C., Lopez-Gomez, I., Hervas, G., & Vazquez, C. (2017) · Cognitive Therapy and Research · doi:10.1007/s10608-016-9778-9 · Cited by 196
de Maat, S. M., Dekker, J., Schoevers, R. A., & de Jonghe, F. (2007) · European Psychiatry · doi:10.1016/j.eurpsy.2006.10.008 · Cited by 192
Vidrine, J. I., Spears, C. A., Heppner, W. L., Reitzel, L. R., Marcus, M. T., Cinciripini, P. M., Waters, A. J., Li, Y., Nguyen, N. T. T., Cao, Y., et al. (2016) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000117 · Cited by 109
de Maat, S., Dekker, J., Schoevers, R., van Aalst, G., Gijsbers-van Wijk, C., Hendriksen, M., Kool, S., Peen, J., Van, R., & de Jonghe, F. (2008) · Depression and Anxiety · doi:10.1002/da.20305 · Cited by 93
“, 1986; Wexler and Cicchetti, 1992] others find combined therapy to be superior [Friedman et al., 2004; Segal et al., 2002].”
Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms
Kurian, B. T., Greer, T. L., & Trivedi, M. H. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.53 · Cited by 73
“EBPT has earned a name both as a monotherapy or as part of combination treatment with antidepressants in achieving remission in depressed patients [95].”
BackgroundOestergaard, S., & Møldrup, C. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.08.014 · Cited by 38
Petersen, T. J., Pava, J. A., Buchin, J., Matthews, J. D., Papakostas, G. I., Nierenberg, A. A., Holmes, A. J., Bogdan, R., Graves, L. M., Harley, R. M., et al. (2010) · Cognitive Therapy and Research · doi:10.1007/s10608-007-9166-6 · Cited by 14
“Specifically, variants of CBT modified to specifically address residual symptoms in patients who have recovered from depression appear to be most efficacious in preventing relapse and recurrence (Segal et al 2002).”
BackgroundPsychotherapy in transplant patients
Schmajuk, M., DeGuzman, E., & Allen, N. (2019) · Psychosocial Care of End-Stage Organ Disease and Transplant Patients · doi:10.1007/978-3-319-94914-7_43 · Cited by 8
Metadata
- Authors
- Segal, Z., Vincent, P., & Levitt, A.
- Venue
- Journal of Psychiatry and Neuroscience
- Publisher
- Canadian Science Publishing
- Published
- 2002-07
- Volume
- 27
- Issue
- 4
- Pages
- 281-290
- ISSN
- 1180-4882 (ISSN-L)
- 1488-2434
- OpenAlex
- W1561344637
- Cited by
- 70
- References
- 10
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.